Suppr超能文献

关于新型冠状病毒肺炎相关急性呼吸窘迫综合征(CARDS)的叙述性综述:“典型”还是“非典型”急性呼吸窘迫综合征?

A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): "typical" or "atypical" ARDS?

作者信息

Pu Dan, Zhai Xiaoqian, Zhou Yuwen, Xie Yao, Tang Liansha, Yin Liyuan, Liu Hangtian, Li Lu

机构信息

Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Ann Transl Med. 2022 Aug;10(16):908. doi: 10.21037/atm-22-3717.

Abstract

BACKGROUND AND OBJECTIVE

The coronavirus disease of 2019 (COVID-19) is highly infectious and mainly involves the respiratory system, with some patients rapidly progress to acute respiratory distress syndrome (ARDS), which is the leading cause of death in COVID-19 patients. Hence, fully understanding the features of COVID-19-related ARDS (CARDS) and early management of this disease would improve the prognosis and reduce the mortality of severe COVID-19. With the development of recent studies which have focused on CARDS, whether CARDS is "typical" or "atypical" ARDS has become a hotly debated topic.

METHODS

We searched for relevant literature from 1999 to 2021 published in PubMed by using the following keywords and their combinations: "COVID-19", "CARDS", "ARDS", "pathophysiological mechanism", "clinical manifestations", "prognosis", and "clinical trials". Then, we analyzed, compared and highlighted the differences between classic ARDS and CARDS from all of the aspects above.

KEY CONTENT AND FINDINGS

Classical ARDS commonly occurs within 1 week after a predisposing cause, yet the median time from symptoms onset to CARDS is longer than that of classical ARDS, manifesting within a period of 9.0-12.0 days. Although the lung mechanics exhibited in CARDS grossly match those of classical ARDS, there are some atypical manifestations of CARDS: the severity of hypoxemia seemed not to be proportional to injury of lung mechanics and an increase of thrombogenic processes. Meanwhile, some patients' symptoms do not correspond with the extent of the organic injury: a chest computed tomography (CT) will reveal the severe and diffuse lung injuries, yet the clinical presentations of patients can be mild.

CONCLUSIONS

Despite the differences between the CARDS and ARDS, in addition to the treatment of antivirals, clinicians should continue to follow the accepted evidence-based framework for managing all ARDS cases, including CARDS.

摘要

背景与目的

2019年冠状病毒病(COVID-19)具有高度传染性,主要累及呼吸系统,部分患者会迅速进展为急性呼吸窘迫综合征(ARDS),这是COVID-19患者死亡的主要原因。因此,全面了解COVID-19相关ARDS(CARDS)的特征并对该疾病进行早期管理,将改善预后并降低重症COVID-19的死亡率。随着近期对CARDS研究的开展,CARDS是“典型”还是“非典型”ARDS已成为一个热议话题。

方法

我们使用以下关键词及其组合在PubMed上检索1999年至2021年发表的相关文献:“COVID-19”“CARDS”“ARDS”“病理生理机制”“临床表现”“预后”及“临床试验”。然后,我们从上述所有方面分析、比较并突出了经典ARDS和CARDS之间的差异。

关键内容与发现

经典ARDS通常在诱发因素出现后1周内发生,然而从症状出现到CARDS的中位时间长于经典ARDS,表现为在9.0 - 12.0天内出现。尽管CARDS中表现出的肺力学大致与经典ARDS相符,但CARDS存在一些非典型表现:低氧血症的严重程度似乎与肺力学损伤不成比例以及血栓形成过程增加。同时,一些患者的症状与器官损伤程度不相符:胸部计算机断层扫描(CT)会显示严重且弥漫性的肺损伤,但患者的临床表现可能较轻。

结论

尽管CARDS和ARDS之间存在差异,但除了抗病毒治疗外,临床医生应继续遵循公认的循证框架来管理所有ARDS病例,包括CARDS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384a/9469157/7c07d235d1c2/atm-10-16-908-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验